5
Shared Docs
5
Same-Page
5 / 5
Mentions
s-may- ready-early-2021/5478232002/> (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Modema and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guid
igence-proposes-holding- limited-worldwide-threat-hearing-in-august/> (7/21, Gazis, 3.68M) reports that DNI Ratcliffe "has proposed appearing before the Senate Intelligence Committee for a partially open hearing on worldwide threats in early August. But he suggested that the majority of the hearing, including a traditional questi
. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker
ther intelligence community officials warned about China's increased capability to interfere in U.S. elections in separate classified hearings with the Senate Intelligence Committee this week, two sources familiar with the hearings tell Axios." Wray and other officials "cited concerns that China is developing the ability to inte
ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized
ersecurity industry's help." In the past, senators "lambasted tech CEOs, demanding answers about social media and aggressive business tactics." But the Senate Intelligence Committee hearings with Microsoft, FireEye, CrowdStrike, and SolarWinds "will provide a glimpse into how a powerful cybersecurity industry and the federal go
rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake
ther intelligence community officials warned about China's increased capability to interfere in U.S. elections in separate classified hearings with the Senate Intelligence Committee this week, two sources familiar with the hearings tell Axios." Wray and other officials "cited concerns that China is developing the ability to int
rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake
ther intelligence community officials warned about China's increased capability to interfere in U.S. elections in separate classified hearings with the Senate Intelligence Committee this week, two sources familiar with the hearings tell Axios." Wray and other officials "cited concerns that China is developing the ability to int
Entities connected to both Johnson & Johnson and the Senate Intelligence Committee

Jeffrey Epstein
PERSON
Donald Trump
PERSON
Joe Biden
PERSON
Prince Andrew
PERSON
Department of Justice
ORGANIZATIONLeon Black
PERSON
Virginia Giuffre
PERSON
Bloomberg L.P.
ORGANIZATION
Scarlett Johansson
PERSONThe New York Post
ORGANIZATION
United States
LOCATION
George W. Bush
PERSON
Michael Jackson
PERSON
Prince Charles
PERSON
Eric Trump
PERSON
USA Today
ORGANIZATION
Julie K. Brown
PERSON
Barack Obama
PERSON
Scarborough
PERSON
Minnesota
LOCATION